BioFuture™ 2023 Wraps Up After Convening Hundreds of High-Profile Attendees and Record Numbers of Investors and Media
Demy-Colton’s BioFuture™ concluded this week after bringing together hundreds of life sciences, diagnostics, pharmaceutical, health delivery and digital health pioneers – including more than 80 speakers, 150 forward-thinking investors and 50 journalists.
- Demy-Colton’s BioFuture™ concluded this week after bringing together hundreds of life sciences, diagnostics, pharmaceutical, health delivery and digital health pioneers – including more than 80 speakers, 150 forward-thinking investors and 50 journalists.
- Participants assembled in New York to weigh in on what lies ahead in healthcare and bioscience.
- Sara Jane Demy, Founder and CEO of Demy-Colton, said, “We've always believed in the transformative power of collaboration and industry-wide synergies.
- Those interested in accessing program content can log into the partnering platform, HelloPartnering, with their registration information.